Thu, 19 Jul 2018 01:25:05 GMT
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Thu, 19 Jul 2018 00:34:49 GMT

KTNV Las Vegas

UNLV School of Medicine welcomes class of 2022
KTNV Las Vegas
The UNLV School of Medicine welcomed its second class to campus this week. 60 students will make up the class of 2022. They come from more than 30 colleges and universities but all have strong ties to Southern Nevada. One of the goals of UNLV's School ...

and more »
Thu, 19 Jul 2018 00:17:58 GMT

Express.co.uk

SNP fees policy blamed as fewer Scots study medicine
Express.co.uk
Statistics show 2,160 Scottish students enrolled on clinical medicine courses at institutions such as Glasgow, Edinburgh, St Andrews and Aberdeen last year. That compares to 2,210 in 2015-16, and 2,350 in 2013-14. When the SNP were swept into office in ...

and more »
Wed, 18 Jul 2018 22:48:13 GMT

Sherbrooke Record

Family medicine “the greatest failure” of the Liberal party – Legault
Sherbrooke Record
Coalition Avenir Quebec (CAQ) leader Francois Legault was in Sherbrooke on Wednesday to announce his commitments to family medicine in the province if elected. He is seen here surrounded by the CAQ candidates in the Eastern Townships ridings of ...

Wed, 18 Jul 2018 22:32:37 GMT

Alcohol-related cirrhosis deaths skyrocket in young adults
EurekAlert (press release)
Liver specialist Elliot B. Tapper, M.D., says he's witnessed the disturbing shift in demographics among the patients with liver failure he treats at Michigan Medicine. National data collected by Tapper and study co-author Neehar Parikh, M.D., M.S ...

and more »
Wed, 18 Jul 2018 22:00:14 GMT

Spinal Cord Stimulation for Disk Degeneration: Pain Medicine News Report
MedPage Today
Researchers have found that spinal cord stimulation can reduce pain in patients with lumbar degenerative disk disease. The type of provider a patient sees influences whether that patient receives an opioid prescription to treat low back pain, a new ...

Wed, 18 Jul 2018 21:48:26 GMT

Global Personalized Medicine Market Report 2018: Focus on Scientific and Commercial Aspects 2016-2026
PR Newswire (press release)
This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics,pharmacoproteomics, and metabolomics. Basic technologies of molecular diagnostics play an important role, particularly ...

and more »
Wed, 18 Jul 2018 21:45:00 GMT

Financial Post

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of ...
Financial Post
VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA ...

and more »
Wed, 18 Jul 2018 21:41:23 GMT

How OU Medicine physicians cared for a newborn born with no immune system
Becker's Hospital Review
A blood test Oklahoma added to its mandatory newborn screening panel three years ago helped physicians at Oklahoma City-based The Children's Hospital at OU Medicine prepare for the birth of a patient with a rare genetic disorder that seriously ...

Wed, 18 Jul 2018 21:35:35 GMT

AAFP News

Community Colleges Hold Key to Family Medicine Diversity
AAFP News
It's also no secret that family medicine owns a bigger chunk of the primary care pie than any other specialty. When combined, those factors provide an enticing backdrop for newly published research in which authors make the case for utilizing America's ...

Wed, 18 Jul 2018 21:27:00 GMT

Business Wire (press release)

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of ...
Business Wire (press release)
BUSINESS WIRE)--VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which ...

and more »